Mitchell Hallman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mitchell Hallman has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Chawon Yun
Department of Pharmacy, College of Pharmacy, Research Institute for Drug Development, Pusan National University, Busan 46241, Republic of Korea
3 shared publications - Erin L. Hsu
Department of Orthopaedic Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA
3 shared publications - Soyeon Jeong
Department of Orthopaedic Surgery Northwestern University Chicago Illinois USA
3 shared publications - Adam E. Jakus
Co-Founder & Chief Technology OfficerDimension Inx Corp.Chicago, IL, United States
2 shared publications - Allison C. Greene
Simpson Querrey Institute for BioNanotechnology, Northwestern University, Chicago, IL, 60611, United States; Department of Orthopaedic Surgery, Northwestern University, Chicago, IL, 60611, United States
2 shared publications - David J. Ellenbogen
Section of Orthopaedic Surgery, Henry Ford Providence Hospital, Southfield, Michigan, USA
2 shared publications
Latest Publications
- Open Access
The effect of local steroid application on bony fusion in a rat posterolateral spinal arthrodesis model
Introduction: Local steroid administration during anterior cervical spine surgery has been shown to improve postoperative dysphagia. However, concerns over potential complications remain. This study aims to evaluate the effect of local steroid administration on bone regeneration and spine fusion in a preclinical model, as well as the impact on osteogenic differentiation of human bone marrow‐derived mesenchymal stem cells (hBM‐MSCs) in a 3D culture system.Materials and methods: Forty‐five rats underwent bilateral L4‐L5 posterolateral lumbar fusion (PLF) utilizing local delivery of low‐dose recombinant human bone morphogenetic protein‐2 (rhBMP‐2; 0.5 μg/implant). Rats were divided into three groups: no steroid (control), low dose (0.5 mg/kg), and high dose (2.5 mg/kg) of triamcinolone. Bone growth and fusion were assessed using radiography, blinded manual palpation, and micro‐CT analysis and were visualized by histology. The impact of triamcinolone exposure on osteogenic differentiation of hBM‐MSCs was evaluated by gene expression analysis, alkaline phosphatase activity assay, and alizarin red staining.Results: No significant differences in fusion scores or rates were seen in the low‐ or high‐dose steroid treatment groups relative to untreated controls. Quantification of new bone formation via micro‐CT imaging revealed no significant between‐group differences in the volume of newly regenerated bone. Triamcinolone also had no negative impact on pro‐osteogenic gene transcript levels, and ALP activity was enhanced in the presence of triamcinolone. Mineral deposition appeared comparable in cultures grown with and without triamcinolone.Conclusions: Local steroid application does not seem to inhibit rhBMP‐2‐mediated spine fusion in rats, though our study may not be adequately powered to detect differences in fusion as measured by manual palpation or bone volume as measured by micro‐CT. These findings suggest that local triamcinolone may not increase pseudarthrosis in spine fusion procedures. Further large animal and clinical studies to verify its safety and efficacy are warranted.
Open AccessThe effect of local steroid application on bony fusion in a rat posterolateral spinal arthrodesis model
Introduction: Local steroid administration during anterior cervical spine surgery has been shown to improve postoperative dysphagia. However, concerns over potential complications remain. This study aims to evaluate the effect of local steroid administration on bone regeneration and spine fusion in a preclinical model, as well as the impact on osteogenic differentiation of human bone marrow‐derived mesenchymal stem cells (hBM‐MSCs) in a 3D culture system.Materials and methods: Forty‐five rats underwent bilateral L4‐L5 posterolateral lumbar fusion (PLF) utilizing local delivery of low‐dose recombinant human bone morphogenetic protein‐2 (rhBMP‐2; 0.5 μg/implant). Rats were divided into three groups: no steroid (control), low dose (0.5 mg/kg), and high dose (2.5 mg/kg) of triamcinolone. Bone growth and fusion were assessed using radiography, blinded manual palpation, and micro‐CT analysis and were visualized by histology. The impact of triamcinolone exposure on osteogenic differentiation of hBM‐MSCs was evaluated by gene expression analysis, alkaline phosphatase activity assay, and alizarin red staining.Results: No significant differences in fusion scores or rates were seen in the low‐ or high‐dose steroid treatment groups relative to untreated controls. Quantification of new bone formation via micro‐CT imaging revealed no significant between‐group differences in the volume of newly regenerated bone. Triamcinolone also had no negative impact on pro‐osteogenic gene transcript levels, and ALP activity was enhanced in the presence of triamcinolone. Mineral deposition appeared comparable in cultures grown with and without triamcinolone.Conclusions: Local steroid application does not seem to inhibit rhBMP‐2‐mediated spine fusion in rats, though our study may not be adequately powered to detect differences in fusion as measured by manual palpation or bone volume as measured by micro‐CT. These findings suggest that local triamcinolone may not increase pseudarthrosis in spine fusion procedures. Further large animal and clinical studies to verify its safety and efficacy are warranted.
- 1 June 2021
- Published by Elsevier in Acta Biomaterialia
- Vol. 127, 146-158
Osteoinductivity and biomechanical assessment of a 3D printed demineralized bone matrix-ceramic composite in a rat spine fusion model
- 1 June 2021
- Published by Elsevier in Acta Biomaterialia
- Vol. 127, 146-158
Osteoinductivity and biomechanical assessment of a 3D printed demineralized bone matrix-ceramic composite in a rat spine fusion model
- Open Access
- 1 January 2021
- Published by SAGE Publications in Tissue Engineering Part A
- Vol. 27 (1-2) , 26-36
Influence of Geometry and Architecture on the In Vivo Success of 3D-Printed Scaffolds for Spinal Fusion
We previously developed a recombinant growth factor-free, 3D-printed material comprised of hydroxyapatite (HA) and demineralized bone matrix (DBM) for bone regeneration. This material has demonstrated the capacity to promote re-mineralization of the DBM particles within the scaffold struts and shows potential to promote successful spine fusion. Here, we investigate the role of geometry and architecture in osteointegration, vascularization, and facilitation of spine fusion in a pre-clinical model. Inks containing HA and DBM particles in a poly(lactide-co-glycolide) elastomer were 3D-printed into scaffolds with varying relative strut angles (90° vs. 45° advancing angle), macropore size (0 vs. 500 vs. 1000 μm), and strut alignment (aligned vs. offset). The following configurations were compared with scaffolds containing no macropores: 90°/500μm/aligned, 45°/500μm/aligned, 90°/1,000μm/aligned, 45°/1,000μm/aligned, 90°/1,000μm/offset, 45°/1,000μm/offset. Eighty-four female Sprague-Dawley rats underwent spine fusion with bilateral placement of the various scaffold configurations (n=12/configuration). Osteointegration and vascularization were assessed using microComputed Tomography and histology, and spine fusion was assessed via blinded manual palpation. The 45°/1,000μm scaffolds with aligned struts achieved the highest average fusion score (1.61/2) as well as the highest osteointegration score. Both the 45°/1,000μm/aligned and 90°/1,000μm/aligned scaffolds elicited fusion rates of 100%, which was significantly greater than the 45°/500μm/aligned iteration (p<0.05). All porous scaffolds were fully vascularized, with blood vessels present in every macropore. Vessels were also observed extending from the native transverse process bone, through the protrusions of new bone, and into the macropores of the scaffolds. When viewed independently, scaffolds printed with relative strut angles of 45° and 90° each allowed for osteointegration sufficient to stabilize the spine at L4-L5. Within those parameters, a pore size of 500 μm or greater was generally sufficient to achieve unilateral fusion. However, our results suggest that scaffolds printed with the larger pore size and with aligned struts at an advancing angle of 45° may represent the optimal configuration to maximize osteointegration and fusion capacity. Overall, this work suggests that the HA/DBM composite scaffolds provide a conducive environment for bone regeneration as well as vascular infiltration. This technology therefore represents a novel, growth-factor-free biomaterial with significant potential as a bone graft substitute for use in spinal surgery.
- 1 January 2021
- Published by SAGE Publications in Tissue Engineering Part A
- Vol. 27 (1-2) , 26-36
Open AccessInfluence of Geometry and Architecture on the In Vivo Success of 3D-Printed Scaffolds for Spinal Fusion
We previously developed a recombinant growth factor-free, 3D-printed material comprised of hydroxyapatite (HA) and demineralized bone matrix (DBM) for bone regeneration. This material has demonstrated the capacity to promote re-mineralization of the DBM particles within the scaffold struts and shows potential to promote successful spine fusion. Here, we investigate the role of geometry and architecture in osteointegration, vascularization, and facilitation of spine fusion in a pre-clinical model. Inks containing HA and DBM particles in a poly(lactide-co-glycolide) elastomer were 3D-printed into scaffolds with varying relative strut angles (90° vs. 45° advancing angle), macropore size (0 vs. 500 vs. 1000 μm), and strut alignment (aligned vs. offset). The following configurations were compared with scaffolds containing no macropores: 90°/500μm/aligned, 45°/500μm/aligned, 90°/1,000μm/aligned, 45°/1,000μm/aligned, 90°/1,000μm/offset, 45°/1,000μm/offset. Eighty-four female Sprague-Dawley rats underwent spine fusion with bilateral placement of the various scaffold configurations (n=12/configuration). Osteointegration and vascularization were assessed using microComputed Tomography and histology, and spine fusion was assessed via blinded manual palpation. The 45°/1,000μm scaffolds with aligned struts achieved the highest average fusion score (1.61/2) as well as the highest osteointegration score. Both the 45°/1,000μm/aligned and 90°/1,000μm/aligned scaffolds elicited fusion rates of 100%, which was significantly greater than the 45°/500μm/aligned iteration (p<0.05). All porous scaffolds were fully vascularized, with blood vessels present in every macropore. Vessels were also observed extending from the native transverse process bone, through the protrusions of new bone, and into the macropores of the scaffolds. When viewed independently, scaffolds printed with relative strut angles of 45° and 90° each allowed for osteointegration sufficient to stabilize the spine at L4-L5. Within those parameters, a pore size of 500 μm or greater was generally sufficient to achieve unilateral fusion. However, our results suggest that scaffolds printed with the larger pore size and with aligned struts at an advancing angle of 45° may represent the optimal configuration to maximize osteointegration and fusion capacity. Overall, this work suggests that the HA/DBM composite scaffolds provide a conducive environment for bone regeneration as well as vascular infiltration. This technology therefore represents a novel, growth-factor-free biomaterial with significant potential as a bone graft substitute for use in spinal surgery.